loadpatents
name:-0.46835899353027
name:-0.0086960792541504
name:-0.029968023300171
Dandapat; Abhijit Patent Filings

Dandapat; Abhijit

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dandapat; Abhijit.The latest application filed is for "il-2 dependent nk-92 cells with stable fc receptor expression".

Company Profile
3.1.11
  • Dandapat; Abhijit - San Diego CA
  • Dandapat; Abhijit - Lexington MA
  • Dandapat; Abhijit - El Segundo CA
  • Dandapat; Abhijit - Culver City CA
  • DANDAPAT; Abhijit - Minneapolis MN
  • Dandapat; Abhijit - Galveston TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Il-2 Dependent Nk-92 Cells With Stable Fc Receptor Expression
App 20220017594 - Navarro; Francisco ;   et al.
2022-01-20
Methods For Producing Fibroadipogenic Progenitor Cells
App 20210388321 - Kyba; Michael S. ;   et al.
2021-12-16
Fc-epsilon Car
App 20210347850 - Boissel; Laurent H. ;   et al.
2021-11-11
Elimination Of Pd-l1-positive Malignancies By Pd-l1 Chimeric Antigen Receptor-expressing Nk Cells
App 20210322477 - Klingemann; Hans G. ;   et al.
2021-10-21
Elimination Of Pd-l1-positive Malignancies By Pd-l1 Chimeric Antigen Receptor-expressing Nk Cells
App 20210315934 - Klingemann; Hans G. ;   et al.
2021-10-14
Elimination of PD-L1-positive malignancies by PD-L1 chimeric antigen receptor-expressing NK cells
Grant 11,077,143 - Klingemann , et al. August 3, 2
2021-08-03
FC-EPSILON CAR (Very imp commercially - in clinical trial)
App 20210198342 - Boissel; Laurent H. ;   et al.
2021-07-01
Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation
App 20210040175 - Klingemann; Hans G. ;   et al.
2021-02-11
Use Of Cd33car Modified High Affinity Nk Cells (t-hank) To Reduce Myeloid-derived Suppressor Cells Suppressor Activity (or Reduce Negative Impact On Nk Cell Activity)
App 20210038645 - Soon-Shiong; Patrick ;   et al.
2021-02-11
Elimination Of Pd-l1-positive Malignancies By Pd-l1 Chimeric Antigen Receptor-expressing Nk Cells
App 20200129552 - Klingemann; Hans G. ;   et al.
2020-04-30
Methods Of Preparing A Primary Cell Sample
App 20180230434 - LAING; Lance Gavin ;   et al.
2018-08-16
Compositions And Methods For The Treatment Of Cardiovascular Conditions
App 20080199434 - Mehta; Jawahar L. ;   et al.
2008-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed